Usefulness of the CAT, LCOPD, EQ-5D and COPDSS scales in understanding the impact of lung disease in patients with alpha-1 antitrypsin deficiency. (Q48076378)

From Wikidata

Jump to navigation Jump to search

scientific article published on 15 May 2014

Language	Label	Description	Also known as
English	Usefulness of the CAT, LCOPD, EQ-5D and COPDSS scales in understanding the impact of lung disease in patients with alpha-1 antitrypsin deficiency.	scientific article published on 15 May 2014

Statements

scholarly article

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24832005

Usefulness of the CAT, LCOPD, EQ-5D and COPDSS scales in understanding the impact of lung disease in patients with alpha-1 antitrypsin deficiency. (English)

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24832005

1 reference

based on heuristic

inferred from title

Marc Miravitlles

8

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24832005

author name string

Sandra Manca

1

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24832005

Esther Rodriguez

2

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24832005

Arturo Huerta

3

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24832005

Maria Torres

4

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24832005

Lourdes Lazaro

5

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24832005

Sergio Curi

6

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24832005

Pietro Pirina

7

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24832005

language of work or name

0 references

publication date

15 May 2014

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24832005

COPD: Journal of Chronic Obstructive Pulmonary Disease

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24832005

11

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24832005

480-488

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24832005

5

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24832005

Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.898030

21 January 2018

Alpha-1-antitrypsin and other proteinase inhibitors

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.898030

21 January 2018

Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ).

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.898030

21 January 2018

Factors associated with the evolution of lung function in patients with alpha-1 antitrypsin deficiency in the Spanish registry

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.898030

21 January 2018

Correlating changes in lung function with patient outcomes in chronic obstructive pulmonary disease: a pooled analysis

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.898030

21 January 2018

Impact of obstructive airways disease on quality of life in older adults

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.898030

21 January 2018

Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.898030

21 January 2018

The relationship of chronic sputum expectoration to physiologic, radiologic, and health status characteristics in alpha(1)-antitrypsin deficiency (PiZ).

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.898030

21 January 2018

Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.898030

21 January 2018

Development and validation of a survey-based COPD severity score

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.898030

21 January 2018

Validation of the COPD severity score for use in primary care: the NEREA study.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.898030

21 January 2018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.898030

21 January 2018

EuroQol--a new facility for the measurement of health-related quality of life

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.898030

21 January 2018

Development and validation of the living with chronic obstructive pulmonary disease questionnaire.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.898030

21 January 2018

Development and first validation of the COPD Assessment Test.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.898030

21 January 2018

Variability of pulmonary function in alpha-1-antitrypsin deficiency: clinical correlates.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.898030

21 January 2018

Clinical phenotypes of Italian and Spanish patients with α1-antitrypsin deficiency.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.898030

21 January 2018

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.898030

21 January 2018

Exacerbations in subjects with alpha-1 antitrypsin deficiency receiving augmentation therapy.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.898030

21 January 2018

Exacerbations in {alpha}1-antitrypsin deficiency.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.898030

21 January 2018

Correlation between annual change in health status and computer tomography derived lung density in subjects with alpha1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.898030

21 January 2018

Differences in adjustment between individuals with alpha-1 antitrypsin deficiency (AATD)-associated COPD and non-AATD COPD.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.898030

21 January 2018

Beyond FEV₁ in COPD: a review of patient-reported outcomes and their measurement

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.898030

21 January 2018

Properties of the COPD assessment test in a cross-sectional European study.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.898030

21 January 2018

Global Initiative for Chronic Obstructive Lung Disease 2011 symptom/risk assessment in α1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.898030

21 January 2018

Usefulness of the LCOPD, CAFS and CASIS scales in understanding the impact of COPD on patients.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.898030

21 January 2018

The living with chronic obstructive pulmonary disease scale was successfully adapted for use in Southern European (Italian and Spanish) and Eastern European (Russian) cultures.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.898030

21 January 2018

Measurement of COPD severity using a survey-based score: validation in a clinically and physiologically characterized cohort

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.898030

21 January 2018

COPD severity score as a predictor of failure in exacerbations of COPD. The ESFERA study.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2014.898030

21 January 2018

Identifiers

10.3109/15412555.2014.898030

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24832005

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24832005

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48076378&oldid=1518867089"